BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld
Home
» Other news to note for June 3, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for June 3, 2021
June 3, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aavantibio, Afimmune, Alk, Bayer, Bioversys, Corbus, Cynata, Evaxion, Eversana, Glaxosmithkline, Histogen, Hoth, IGM, Immutep, Merck, Mindcure, Mindset, Moderna, Monopar, National, Noria, Ocugen, Organon, Otonomy, Oyster Point, Rain, RDIF, Resverlogix, Tekcyte, Tempus, Wave.
BioWorld
Briefs
Other news to note
Coronavirus